We are live on ! Find out more
NYLIM

New York Life Investment Management Portfolio holdings

AUM $14.3B
1-Year Est. Return 34.42%
This Fund
S&P 500
This Quarter Est. Return
+6.71%
1 Year Est. Return
+34.42%
3 Year Est. Return
+100.17%
5 Year Est. Return
+116.66%
10 Year Est. Return
+182.12%
AUM
$10.3B
AUM Growth
+$337M
Cap. Flow
-$216M
Cap. Flow %
-2.1%
Top 10 Hldgs %
26.43%
Holding
895
New
48
Increased
122
Reduced
665
Closed
50

Sector Composition

Rank Sector Weight
1 Technology 23.15%
2 Financials 8.96%
3 Healthcare 8.19%
4 Consumer Discretionary 7.36%
5 Communication Services 5.95%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
PLNT icon
726
Planet Fitness
PLNT
$3.67B
$861K 0.01%
10,602
-673
-6% -$52.7K
ETSY icon
727
Etsy
ETSY
$7.24B
$845K 0.01%
15,224
-16,554
-52% -$939K
LSCC icon
728
Lattice Semiconductor
LSCC
$18.4B
$836K 0.01%
15,754
-1,324
-8% -$67.8K
PCTY icon
729
Paylocity
PCTY
$7.62B
$834K 0.01%
5,055
-290
-5% -$44.1K
TREX icon
730
Trex
TREX
$5.06B
$832K 0.01%
+12,496
New +$877K
KEX icon
731
Kirby Corp
KEX
$7.24B
$828K 0.01%
+6,760
New +$806K
ARW icon
732
Arrow Electronics
ARW
$10.7B
$825K 0.01%
6,210
-356
-5% -$45.1K
ITCI
733
DELISTED
Intra-Cellular Therapies Inc.
ITCI
$823K 0.01%
11,247
+375
+3% +$28.2K
BPOP icon
734
Popular Inc
BPOP
$11.3B
$820K 0.01%
8,174
-469
-5% -$45.7K
DINO icon
735
HF Sinclair
DINO
$15.7B
$807K 0.01%
18,104
-291
-2% -$13.9K
RVMD icon
736
Revolution Medicines
RVMD
$43.9B
$807K 0.01%
+17,791
New +$775K
RHI icon
737
Robert Half
RHI
$4.3B
$805K 0.01%
11,948
-685
-5% -$43.4K
CGNX icon
738
Cognex
CGNX
$10.2B
$801K 0.01%
19,787
-1,135
-5% -$48.3K
GNTX icon
739
Gentex
GNTX
$4.9B
$799K 0.01%
26,915
-1,543
-5% -$47.9K
BSV icon
740
Vanguard Short-Term Bond ETF
BSV
$45.7B
$790K 0.01%
10,038
+311
+3% +$24.2K
ALV icon
741
Autoliv
ALV
$8.83B
$789K 0.01%
8,451
-484
-5% -$48.2K
EXEL icon
742
Exelixis
EXEL
$12.4B
$787K 0.01%
30,314
-3,550
-10% -$88.2K
ANF icon
743
Abercrombie & Fitch
ANF
$4.92B
$784K 0.01%
+5,606
New +$853K
JAZZ icon
744
Jazz Pharmaceuticals
JAZZ
$16.1B
$782K 0.01%
7,017
-403
-5% -$44.2K
CFB
745
DELISTED
CrossFirst Bankshares, Inc. Common Stock
CFB
$780K 0.01%
+46,759
New +$788K
MKSI icon
746
MKS Inc
MKSI
$20.8B
$778K 0.01%
7,157
-410
-5% -$48.7K
MTN icon
747
Vail Resorts
MTN
$5.16B
$778K 0.01%
4,463
-419
-9% -$75K
LSTR icon
748
Landstar System
LSTR
$6.39B
$777K 0.01%
4,116
-236
-5% -$43.5K
AZEK
749
DELISTED
The AZEK Co
AZEK
$773K 0.01%
16,512
-947
-5% -$40.6K
CRUS icon
750
Cirrus Logic
CRUS
$6.14B
$770K 0.01%
+6,199
New +$821K

Similar funds

New York Life Investment Management's Q3 2024 Portfolio in Review

As of Q3 2024, New York Life Investment Management held 895 positions worth $10.3B, up 3.4% from $9.95B the previous quarter. Its ten largest holdings account for 26% of the portfolio.

New York Life Investment Management's Q3 2024 filing shows 48 new, 122 increased, 665 reduced and 50 closed positions. Its largest new stake was iShares 0-1 Year Treasury Bond ETF: 70,121 shares worth $7.76M. The largest sale was NVIDIA, an estimated $32.3M.

By sector, the portfolio is most concentrated in Technology at 23% of assets, down from 24% a quarter earlier, followed by Financials and Healthcare.

  • New York Life Investment Management's largest Q3 2024 buy was iShares 0-1 Year Treasury Bond ETF: 70,121 shares worth $7.76M.
  • New York Life Investment Management added most to IQ Winslow Large Cap Growth ETF in Q3 2024, an estimated $19.4M increase.
  • New York Life Investment Management's biggest Q3 2024 reduction was NVIDIA, cutting an estimated $32.3M.
  • New York Life Investment Management fully exited Equitrans Midstream Corporation Common Stock in Q3 2024, selling an estimated $15.2M.
  • New York Life Investment Management's ten largest holdings make up 26% of its $10.3B portfolio in Q3 2024.
  • New York Life Investment Management opened 48 new positions and closed 50 in Q3 2024.
  • New York Life Investment Management's portfolio value rose 3.4% quarter-over-quarter to $10.3B.

Based on New York Life Investment Management's 13F filing for Q3 2024, filed 7 Nov 2024.